MX2022000520A - Compuestos moduladores del receptor de estrogeno. - Google Patents

Compuestos moduladores del receptor de estrogeno.

Info

Publication number
MX2022000520A
MX2022000520A MX2022000520A MX2022000520A MX2022000520A MX 2022000520 A MX2022000520 A MX 2022000520A MX 2022000520 A MX2022000520 A MX 2022000520A MX 2022000520 A MX2022000520 A MX 2022000520A MX 2022000520 A MX2022000520 A MX 2022000520A
Authority
MX
Mexico
Prior art keywords
estrogen receptor
modulating compounds
compounds
receptor modulators
estrogen
Prior art date
Application number
MX2022000520A
Other languages
English (en)
Inventor
Chris P Miller
Original Assignee
Radius Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radius Pharmaceuticals Inc filed Critical Radius Pharmaceuticals Inc
Publication of MX2022000520A publication Critical patent/MX2022000520A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere a compuestos que son moduladores del receptor de estrógeno. También se describen composiciones farmacéuticas y medicamentos que incluyen los compuestos descritos en la presente, así como también métodos para usar tales moduladores del receptor de estrógeno, solo y en combinación con otros compuestos, para tratar enfermedades o condiciones que son mediadas o dependientes de los receptores de estrógeno.
MX2022000520A 2019-07-22 2020-07-21 Compuestos moduladores del receptor de estrogeno. MX2022000520A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962876963P 2019-07-22 2019-07-22
PCT/US2020/042903 WO2021016254A1 (en) 2019-07-22 2020-07-21 Estrogen receptor-modulating compounds

Publications (1)

Publication Number Publication Date
MX2022000520A true MX2022000520A (es) 2022-02-10

Family

ID=71995156

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022000520A MX2022000520A (es) 2019-07-22 2020-07-21 Compuestos moduladores del receptor de estrogeno.

Country Status (10)

Country Link
US (1) US20220281875A1 (es)
EP (1) EP4003996A1 (es)
JP (1) JP2022541610A (es)
KR (1) KR20220035942A (es)
AU (1) AU2020315812A1 (es)
BR (1) BR112022000553A2 (es)
CA (1) CA3146365A1 (es)
IL (1) IL289869A (es)
MX (1) MX2022000520A (es)
WO (1) WO2021016254A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113105329B (zh) * 2021-04-22 2023-10-03 成都道合尔医药技术有限公司 一种(e)-甲酯3-(3,5-二氟-4-甲酰基苯基)丙烯酸的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2300857B (en) * 1995-05-19 1998-07-08 Pharmacia Spa Indazole [3,2-e] -pyrrole and 1,2,3 -benzotriazole [3,2-e] -pyrrole derivatives
CA3089298A1 (en) * 2018-01-22 2019-07-25 Radius Pharmaceuticals, Inc. Estrogen receptor-modulating compounds

Also Published As

Publication number Publication date
WO2021016254A1 (en) 2021-01-28
JP2022541610A (ja) 2022-09-26
KR20220035942A (ko) 2022-03-22
EP4003996A1 (en) 2022-06-01
IL289869A (en) 2022-03-01
AU2020315812A1 (en) 2022-03-17
BR112022000553A2 (pt) 2022-05-17
US20220281875A1 (en) 2022-09-08
CA3146365A1 (en) 2021-01-28
CN114174297A (zh) 2022-03-11

Similar Documents

Publication Publication Date Title
PH12015502621A1 (en) Estrogen receptor modulator and uses thereof
MX2015016171A (es) Moduladores del receptor de estrogeno de azetidina y usos de los mismos.
PH12015501738A1 (en) Androgen receptor modulators and uses thereof
MX2015011132A (es) Moduladores policiclicos del receptor de estrogenos y sus usos.
PH12014502095A1 (en) Estrogen receptor modulators and uses thereof
MX2013002975A (es) Moduladores de receptores de estrogenos y usos de los mismos.
PH12014501351B1 (en) Fluorinated estrogen receptor modulators and uses thereof
MX2023000677A (es) Compuestos moduladores de receptor de estrogeno.
PH12019502058A1 (en) Farnesoid x receptor agonists and uses thereof
NZ737399A (en) Ccr2 modulators
WO2011156518A3 (en) Estrogen receptor modulators and uses thereof
WO2011159769A3 (en) Indane estrogen receptor modulators and uses thereof
UA122868C2 (uk) Тетрагідропіридо[3,4-в]індолові модулятори естрогенових рецепторів та їх застосування
PH12019500208A1 (en) Spiro-lactam nmda receptor modulators and methods of using same
MX2018009752A (es) 1,2,3,-triazoles sustituidos como moduladores de nmda selectivos de nr2b.
PH12019502576A1 (en) Bis-octahydrophenanthrene carboxamides and protein conjugates thereof
MX2021003110A (es) Agonistas del receptor x farnesoide y usos de los mismos.
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
EA033197B1 (ru) Замещенные 4-азаиндолы и их применение в качестве модуляторов рецептора glun2b
MX2021015508A (es) Carbamatos de piridina y su uso como moduladores del receptor glun2b.
MX2020000693A (es) Compuestos de 1,8-naftiridinona, y usos de los mismos.
MX2020013085A (es) Antagonistas del receptor de subtipo 2 de melanocortina (mc2r) y usos de los mismos.
MX2021015500A (es) Pirazolo-pirazinas sustituidas y su uso como moduladores del receptor glun2b.
CR20220215A (es) Heteroaril bifenil amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1
CR20220216A (es) Aminas de heteroaril-bifenilo para el tratamiento de enfermedades pd-l1